📰 Quest Diagnostics News
Page 31 - Quest Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Quest Diagnostics. Real-time updates on events, politics, business and more.
May 23, 2024
Experts say more drug screens are coming back positive, even with the use of CBD. Here's what to know before buying.
May 23, 2024
Experts say more drug screens are coming back positive, even with the use of CBD. Here's what to know before buying.
May 22, 2024
Neighbors have started to notice the effects of a month-long movement in New York state, and frankly, a majority of residents are upset.
May 21, 2024
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The
May 21, 2024
/PRNewswire/ -- Cancer Biomarkers Market is Segmented by Type (Protein Biomarker, Genetic Biomarker), by Application (Diagnostics, Research). The Global Cancer...
May 21, 2024
NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest colleagues from coast-to-coast marked Lab Week 2024 with a week full of activities to celebrate our medical laboratory professionals and pathologists.
May 21, 2024
NORTHAMPTON, MA / ACCESSWIRE / May 21, 2024 / Quest Diagnostics East Region President Ruth Clements explained how routine diagnostic testing is crucial to closing gaps in healthcare as part of health panel
May 20, 2024
The company reported a 633% increase in the number of diagnostics involving substituted urine between 2022 and 2023. More than 6,000 specimens belonged to an animal, another human being or was synthetic urine purchased online.
May 20, 2024
Philadelphia Trust Co. decreased its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the 4th quarter, HoldingsChannel reports. The fund owned 4,329 shares of the medical research company’s stock after selling 945 shares during the period. Philadelphia Trust Co.’s holdings in Quest Diagnostics were worth $597,000 as of its most recent […]
May 20, 2024
Philadelphia Trust Co. reduced its position in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 17.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,329 shares of the medical research company’s stock after selling 945 shares during the period. Philadelphia Trust Co.’s […]